title: [Significance of primary radical surgery for survival following treatment of breast cancer. Problems of interpretation of treatment results of prospective, nonrandomized studies exemplified by the Southwest Germany Breast Cancer Study].
abstract: In a prospective non-randomised trial 1642 patients were included. After a mean time of 10 years a follow-up analysis was performed. The importance of the radicality of the primary operative therapy of breast cancer should be evaluated. The mean 5 years survival rate was 67.3%, the 10 year survival rate 51.6%. Tumor stage and age had a highly significant influence on the survival rate. Patients with simple mastectomy had a lower survival rate as patients with radical mastectomy. This apparent difference was caused by a different age distribution in the therapy groups. Accordingly the mean life deficiency was the lowest in the simple mastectomy group. In a multiple hazard statistical analysis tumor stage and age showed a highly significant influence on the survival rate. The intraoperative radicality classification showed a significant correlation to the prognoses of the patients. The operative therapy itself had no significant influence on the survival rate of the patients.
authors: Chirurgische Universitätsklinik Heidelberg.
authors: W
authors: W
authors: Friedl
authors: B
authors: B
authors: Henningsen
authors: U
authors: U
authors: Abel
authors: R
authors: R
authors: Hering
authors: P
authors: P
authors: Reichel
authors: F
authors: F
authors: Linder
authors: C
authors: C
authors: Herfarth
mesh_terms: D000328:Adult; D000368:Aged; D001943:Breast Neoplasms / Q000473:pathology / Q000601:surgery*; D003131:Combined Modality Therapy; D005260:Female; D005500:Follow-Up Studies; D005860:Germany, West; D006801:Humans; D008408:Mastectomy; D008875:Middle Aged; D009367:Neoplasm Staging; D011183:Postoperative Complications / Q000401:mortality*; D011446:Prospective Studies
vernacular_title: Die Bedeutung der primären operativen Radikalität für das Uberleben nach Mammacarcinombehandlung. Interpretationsprobleme der Behandlungsergebnisse prospektiver, nichtrandomisierter Studien am Beispiel der Südwestdeutschen Mammacarcinom-Studie.